Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women

Balena, 1993, The effects of 2 year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates, J Clin Invest, 92, 2577, 10.1172/JCI116872

Baud, 1980, Degree of mineralization of bone tissue as determined by quantitative microradiography, 345

Baud, 1975, Morphological and crystallographic analysis of bone mineral, 3

Black, 1996, Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures, Lancet, 348, 1535, 10.1016/S0140-6736(96)07088-2

Boivin, 1984, Microradiographic methods for calcified tissues, 391

Boivin, G., Klaushofer, K., Roschger, P., Rinnerthaler, S., Fratzl, P., Chavassieux, P., Santora, A. C., Yates, A. J., and Meunier, P. J. Alendronate increases the mean degree of mineralization of bone and the uniformity of mineralization of bone in osteoporotic women. [abstract] Bone 23(Suppl.):S477; 1998.

Boivin, 1993, Histomorphometric methods applied to bone, 137

Bone, 1997, Dose-response relationships for alendronate treatment in osteoporotic elderly women, J Clin Endocrinol Metabol, 82, 265, 10.1210/jc.82.1.265

Chavassieux, 1985, Intersample variation in bone histomorphometry, Calcif Tissue Int, 37, 345, 10.1007/BF02553699

Chavassieux, 1997, Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis, J Clin Invest, 100, 1475, 10.1172/JCI119668

Cummings, 1998, Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the Fracture Intervention Trial, JAMA, 280, 2077, 10.1001/jama.280.24.2077

Ensrud, 1997, Treatment with alendronate prevents fractures in women at highest risk, Arch Intern Med, 157, 2617, 10.1001/archinte.157.22.2617

Fleisch, 1997

Fleisch, 1998, Bisphosphonates, Endocrine Rev, 19, 80, 10.1210/er.19.1.80

Francis, 1997, Bisphosphonates in the treatment of osteoporosis in 1997, Curr Ther Res, 58, 656, 10.1016/S0011-393X(97)80101-4

Fratzl, 1996, Effects of sodium fluoride and alendronate on the bone mineral in minipigs, J Bone Miner Res, 11, 248, 10.1002/jbmr.5650110214

Frost, 1985, The skeletal intermediary organization. A synthesis, 49

Garnero, 1996, Markers of bone resorption predict hip fracture in elderly women, J Bone Miner Res, 11, 1531, 10.1002/jbmr.5650111021

Glimcher, 1998, The nature of the mineral phase in bone, 23

Grynpas, 1993, Age and disease-related changes in the mineral of bone, Calcif Tissue Int, 53, S57, 10.1007/BF01673403

Jowsey, 1973, Autoradiographic and microradiographic studies of bone, 297

Jowsey, 1977

Jowsey, 1977

Liberman, 1995, Effect of oral alendronate on bone mineral density and incidence of fractures in postmenopausal osteoporosis, N Engl J Med, 333, 1437, 10.1056/NEJM199511303332201

Meunier, 1997, Bone mineral density reflects bone mass but also the degree of mineralization of bone, Bone, 21, 373, 10.1016/S8756-3282(97)00170-1

Meunier, 1997, Prevention of early postmenopausal bone loss with cyclical etidronate (a double-blind, placebo-controlled study and 1-year follow-up), J Clin Endocrinol Metab, 82, 2784, 10.1210/jc.82.9.2784

Paschalis, 1997, FTIR microspectroscopic analysis of normal human cortical and trabecular bone, Calcif Tissue Int, 61, 480, 10.1007/s002239900371

Paschalis, 1997, FTIR microspectroscopic analysis of human iliac crest biopsies from untreated osteoporotic bone, Calcif Tissue Int, 61, 487, 10.1007/s002239900372

Pols, 1999, Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass, Osteopor Int, 9, 461, 10.1007/PL00004171

Reid, 1987, Changes in the mineral density distribution in human bone with age, J Bone Miner Res, 2, 13, 10.1002/jbmr.5650020104

Rodan, 1997, Bone mass homeostasis and bisphosphonate action, Bone, 20, 1, 10.1016/S8756-3282(96)00318-3

Rodan, 1998, Mechanisms of action of bisphosphonates, Annu Rev Pharmacol Toxicol, 38, 375, 10.1146/annurev.pharmtox.38.1.375

Roschger, 1998, Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies, Bone, 23, 319, 10.1016/S8756-3282(98)00112-4

Roschger, 1997, Mineralization of cancellous bone after alendronate and sodium fluoride treatment, Bone, 20, 393, 10.1016/S8756-3282(97)00018-5

Tucci, 1996, Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis, Am J Med, 101, 488, 10.1016/S0002-9343(96)00282-3